These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6340575)

  • 1. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
    Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine.
    Salerno DM; Fifield J; Farmer C; Hodges M
    Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of a slow-release quinidine preparation and flecainide administered in 2 daily doses for the treatment of extrasystole].
    Clémenty J; Castagne D; Dallocchio M; Bricaud H
    Ann Cardiol Angeiol (Paris); 1984 Oct; 33(6):401-5. PubMed ID: 6208841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
    Dubner SJ; Elencwajg BD; Palma S; Mendelzon R; Ramos A; Bertolasi CA
    Am Heart J; 1985 Mar; 109(3 Pt 1):523-8. PubMed ID: 3883728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
    Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J
    Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias.
    Morganroth J; Somberg JC; Pool PE; Hsu PH; Lee IK; Durkee J; Salerno DM
    J Am Coll Cardiol; 1986 Jan; 7(1):9-16. PubMed ID: 3079781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
    Muhiddin KA; Turner P; Hellestrand K; Camm AJ
    Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drug therapy for suppression of ventricular arrhythmia: experience with 122 patients treated for two years.
    Salerno DM; Fifield J; Hodges M
    J Clin Pharmacol; 1990 Mar; 30(3):226-34. PubMed ID: 2312780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide: a new prototype antiarrhythmic agent.
    Nappi JM; Anderson JL
    Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mexiletine and quinidine in ventricular ectopy.
    Fenster PE; Hanson CD
    Clin Pharmacol Ther; 1983 Aug; 34(2):136-42. PubMed ID: 6347497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of complex ventricular arrhythmias by oral flecainide.
    Duran D; Platia EV; Griffith LS; Adhar G; Reid PR
    Clin Pharmacol Ther; 1982 Nov; 32(5):554-61. PubMed ID: 7127996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm.
    Borgeat A; Goy JJ; Maendly R; Kaufmann U; Grbic M; Sigwart U
    Am J Cardiol; 1986 Sep; 58(6):496-8. PubMed ID: 3529911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flecainide in the treatment of nonsustained ventricular tachycardia.
    Lal R; Chapman PD; Naccarelli GV; Schechtman KB; Rinkenberger RL; Troup PJ; Kim SS; Dougherty AH; Ruffy R
    Ann Intern Med; 1986 Oct; 105(4):493-8. PubMed ID: 3752754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP; Tilley-Gray B
    Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.